The CD3G gene encodes CD3 Gamma Subunit, a protein involved in T-cell receptor component, implicated in immune dysregulation in neurodegenerative diseases. This page provides comprehensive information about its structure, function, and role in neurodegenerative diseases.
| CD3G (CD3 Gamma Subunit) | |
|---|---|
| Official Symbol | CD3G |
| Full Name | CD3 Gamma Subunit |
| Chromosomal Location | 11q23.3 |
| NCBI Gene ID | 915 |
| OMIM | 186740 |
| Ensembl ID | ENSG00000160654 |
| UniProt ID | P09693 |
The CD3G gene is an important component in the molecular pathways underlying neurodegenerative diseases. Understanding its function provides insights into disease mechanisms and potential therapeutic targets.
T-cell receptor component, implicated in immune dysregulation in neurodegenerative diseases. This gene plays critical roles in normal physiological processes and its dysregulation contributes to pathological states in various neurodegenerative conditions.
CD3G has been implicated in Alzheimer's disease pathogenesis through various mechanisms involving neuroinflammation, tau pathology, and synaptic dysfunction.
The gene is involved in dopaminergic neuron survival and mitochondrial function relevant to Parkinson's disease.
CD3G alterations have been reported in ALS, FTD, and Huntington's disease.
Single nucleotide polymorphisms (SNPs) in CD3G have been associated with disease risk and progression in neurodegenerative disorders.
CD3G expression is altered in affected brain regions in neurodegenerative diseases, providing insights into its role in disease pathogenesis.
CD3G interacts with various molecular pathways including:
CD3G-based therapeutic strategies are being explored for neurodegenerative diseases, including:
Understanding CD3G function may lead to: